The BioTechX USA Congress, now entering its third year, is a major two-day event focused on the future of pharmaceutical development and healthcare, specifically covering diagnostics, precision medicine, and digital transformation. Held in Boston, Massachusetts in 2026, the world’s leading biotech hub, the congress aims to gather 1,500 global executives, 300 speakers, 100 sponsors and exhibitors, and 50 innovative start-ups. The event is designed to maintain and foster new relations among key stakeholders, gathering leaders from top pharmaceutical companies, biotechs, healthcare systems, and academic groups to enhance collaboration and networking opportunities.

The comprehensive agenda is organized into eight high-level content tracks that cover the industry’s entire value chain. Topics range from the use and management of multiomic data to the development of personalized therapies, as well as the practical generation of this crucial data. Given the industry’s exponential growth, the congress brings together leaders of biotech, pharma, fast-growing start-ups, and established solution providers to offer deep insights into where the industry is heading next. Attendees also have the opportunity to submit a scientific poster, which will be displayed throughout the two-day event, providing another excellent platform to showcase research in biotechnology and genomics.